Global Pain Relief Therapy Market 2018 Top Companies are Medtronic, Boston Scientific Corporation, Abbott, Johnson & Johnson Services, Inc, Eli Lilly and Company, Merck Sharp & Dohme Corp, Pfizer, Inc, F. Hoffmann La Roche Ltd, DJO Global, Breg Inc, Beie

The Global Pain Relief Therapy Market accounted to USD 900.0 million in 2016 growing at a CAGR of 5.5% during the forecast period of 2017 to 2024. The upcoming market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024. Pain therapy is the most common and adopted methods for the transitory management of pain and sprains, bumps, inflammation, strains, bruises, and arthritis. The therapy is used in providing the relief from all the muscle related ailments. There are various type of therapies such as light therapy, behavioral therapy, etc

Download PDF Sample Copy of Report@ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-pain-relief-therapy-market

 Global Pain Relief Therapy Market By Product Type (Prescription based products, OTC-based products {Pharmaceuticals, Medical Devices}), Mode of Purchase (Over-The-Counter, Prescribed), Application (Musculoskeletal Disorder, Sport Medicine, Post-operative, Post-trauma, Physical Therapy), End-User (Hospitals, Clinics, Ambulatory Centers, Physiotherapy Centers, Homecare Settings), By Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends and Forecast to 2025

Pain relief therapy or pain management is the therapy which is used in treating all types of pain, including musculoskeletal, spinal and neuropathic pain disorders. To reduce severity of pain, and improve patients’ quality of life minimally invasive procedures and proper use of medications are implemented to achieve those goals.

According to the WHO, around 116 mn people were suffering from chronic pain in 2011 in the U.S .According to another survey, one in five people in Europe suffers from chronic pain every year.

Some of the major market players in this market are :-

Medtronic,
Boston Scientific Corporation,
Abbott,
Johnson & Johnson Services, Inc,
Eli Lilly and Company,
Merck Sharp & Dohme Corp,
Pfizer, Inc,
F. Hoffmann La Roche Ltd,
DJO Global, 
Breg Inc,
Beiersdorf global,
Medline Industries, Inc,
3M,
Sanofi,
ROHTO Pharmaceutical Co.,Ltd,
Össur Global,
Hisamitsu Pharmaceutical Co.,In,
Calmar Pain Relief, LLC,
UltraCare PRO,
Polar Products Inc.
Market Segmentation: 
The global market for pain relief therapy by the following sub-categories is presented

By Product Type
Prescription based products
OTC-based products
Pharmaceuticals
Medical Devices
Mode of Purchase
Over-The-Counter
Prescribed
Application
Musculoskeletal Disorder
Sport Medicine
Post-operative
Post-trauma
Physical Therapy
End-User
Hospitals
Clinics
Ambulatory Centers
Physiotherapy Centers
Homecare Settings
By Geography
North America
South America
Europe
Asia-Pacific
Middle East and Africa
FACTORS DRIVING GROWTH IN THE GLOBAL PAIN RELIEF THERAPY MARKET
Rising accidental incidences:

According to statista, in U.S. 6.3 million fatal injuries occurred due to road accidents and more than 1.25 million people die every year as a result of road traffic crashes. Moreover 1214 road crashes occur every day in India.

 According to Association of Safe International Road Travel, around 20-50 million peoples are injured or disabled in road crashes around the globe and this number is increasing year after year. According to the reports injury to the bone as well as chances of fracture, heavy wounds are very high in this kind of cases. This leads the patient to suffer from extreme pain, hence in such case the pain relief therapy is used effectively so the patient should get relief from pain.

To Avail 10% Discount On This Report Mail Us on :-
sopan.gedam@databridgemarketresearch.com

With the increase in incidence of accidents there will be more cases of injuries, hence to manage them the use of pain relief therapy will be in use hence providing this market a strong platform in future. 

Increasing number of chronic diseases:

There are various diseases and conditions in which pain relief therapy are been used such as such as brain tumors,  breast cancer, cervical cancer, Crohn’s disease, head injury, osteoporosis, renal cysts, lung cancer, various fractures, blood clots, fatty liver disease, gallstones etc.

According to a news release on The Hindu in June 2016, brain tumor foundation of India says n India, every year 40,000-50,000 persons are diagnosed with brain tumor. Of these 20 per cent are children. According to the brain tumor statistics in November 2017, an estimated 23,880 adults (13,720 men and 10,160 women) in the United States are diagnosed with primary cancerous tumors of the brain and spinal cord.

According to world health organization, it is estimated that worldwide over 508 000 women died in 2011 due to breast cancer. In most of the developing countries the rate of breast cancer is 40 per 100,000, in eastern Africa it is 19.3 per 100,000, and in Western Europe it is 89.7 per 100,000. And this number is estimated to increase with increasing population.

As with time the rate of chronic diseases is increasing year after year, hence to manage the pain in these chronic diseases, the demand for pain relief therapy will be used, hence providing this market a pool of opportunities in future.

To Inquire before Buy Report @ 
https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-pain-relief-therapy-market

About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com

This release was published on openPR.